Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors

European Journal of Pediatrics

Volumn 174, Issue 5, 2015, Pages 675-686

  Ammann, R A ^a   Laws, H J ^b   Schrey, D ^c   Ehlert, K ^c   Moser, O ^d   Dilloo, D ^d   Bode, U ^d   Wawer, A ^e   Schrauder, A ^f   Cario, G ^f   Laengler, A ^g   Graf, N ^h   Furtwangler R ^h   Simon, A ^h  

^a UNIVERSITY OF BERN   (Switzerland)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g Gemeinschaftskrankenhaus Herdecke   (Germany)

^h University Children   (Germany)

Author keywords

Bloodstream infection; Nosocomial infection; Oncoped study; Paediatric cancer patients; Prospective surveillance

Indexed keywords

BACTEREMIA; BLOOD; BLOODBORNE BACTERIUM; CANCER CENTER; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CHILD; CLINICAL TRIAL; CROSS INFECTION; FEMALE; HOSPITAL; HUMAN; LEUKEMIA, MYELOID, ACUTE; MALE; MICROBIOLOGY; MULTICENTER STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE;

BACTEREMIA; BLOOD-BORNE PATHOGENS; CANCER CARE FACILITIES; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CHILD; CROSS INFECTION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84939943755     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2525-5     Document Type: Article

References (57)

1. Abbas AA, Fryer CJ, Paltiel C, Chedid F, Felimban SK, Yousef AA, Khattab TM (2004) Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 42(4):325–331
2. Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I (2006) Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28(1):23–28
3. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J, Levy I (2006) Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 62(3):358–365
4. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS (2008) Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 51(1):53–58. doi:10.1002/pbc.21497
5. Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kuhne T, Popovic MB, Luthy AR, Aebi C (2010) Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 28(12):2008–2014. doi:10.1200/JCO.2009.25.8988
6. Ammann RA, Tissing WJ, Phillips B (2012) Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis 25(3):258–265. doi:10.1097/QCO.0b013e328351d199
7. Barrell C, Covington L, Bhatia M, Robison J, Patel S, Jacobson JS, Buet A, Graham PL, Saiman L (2012) Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients. Am J Infect Control 40(5):434–439. doi:10.1016/j.ajic.2011.06.002
8. Beutel K, Simon A (2005) Diagnostic and management of central venous line infections in pediatric cancer patients. Klin Padiatr 217(Suppl 1):91–100
9. Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ (2010) Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 29(4):464–468. doi:10.1016/j.clnu.2009.12.005
10. Biwersi C, Hepping N, Bode U, Fleischhack G, von Renesse A, Exner M, Engelhart S, Gieselmann B, Simon A (2009) Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health 212(5):541–546. doi:10.1016/j.ijheh.2009.01.003
11. Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B, Moroni C, Morreale G, Timitilli A, Tripodi G, Lanino E, Haupt R (2008) Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 41(4):339–347. doi:10.1038/sj.bmt.1705921
12. Castagnola E, Conte M, Parodi S, Papio F, Caviglia I, Haupt R (2007) Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr Blood Cancer 49(5):672–677
13. Castagnola E, Faraci M, Moroni C, Bandettini R, Caruso S, Bagnasco F, Caviglia I, Natalizia AR, de Fazio V, Morreale G, Lanino E, Dini G, Haupt R (2008) Bacteremias in children receiving hemopoietic SCT. Bone Marrow Transplant 41(Suppl 2):S104–S106. doi:10.1038/bmt.2008.66
14. Castagnola E, Garre ML, Bertoluzzo L, Pignatelli S, Pavanello M, Caviglia I, Caruso S, Bagnasco F, Moroni C, Tacchella A, Haupt R (2011) Epidemiology of febrile neutropenia in children with central nervous system tumor: results from a single center prospective study. J Pediatr Hematol Oncol 33(7):e310–e315. doi:10.1097/MPH.0b013e31822bf6ec
15. Cecinati V, Brescia L, Tagliaferri L, Giordano P, Esposito S (2012) Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis 31(11):2869–2877. doi:10.1007/s10096-012-1652-4
16. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R, Hachem R, Raad I (2003) Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36(1):116–119
17. Choi SW, Chang L, Hanauer DA, Shaffer-Hartman J, Teitelbaum D, Lewis I, Blackwood A, Akcasu N, Steel J, Christensen J, Niedner MF (2013) Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods. Pediatr Blood Cancer 60(2):262–269. doi:10.1002/pbc.24187
18. Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U, Ruden H, Daschner FD (2003) Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31(9):795–801
19. Dettenkofer M, Wenzler-Röttele S, Babikir R, Bertz H, Ebner W, Meyer E, Rüden H, Gastmeier P, Daschner F, the Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40:926–931
20. Dumichen MJ, Seeger K, Lode HN, Kuhl JS, Ebell W, Degenhardt P, Singer M, Geffers C, Querfeld U (2012) Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J Hosp Infect 80(4):304–309. doi:10.1016/j.jhin.2012.01.003
21. El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L (2011) Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. Pediatr Blood Cancer 57(2):283–288. doi:10.1002/pbc.22926
22. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R (2005) Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 16(4):648–654
23. Gapany C, Tercier S, Diezi M, Clement C, Lemay K, Joseph JM (2011) Frequent accesses to totally implanted vascular ports in pediatric oncology patients are associated with higher infection rates. J Vasc Access 12(3):207–210
24. Gaur AH, Bundy DG, Gao C, Werner EJ, Billett AL, Hord JD, Siegel JD, Dickens D, Winkle C, Miller MR (2013) Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol 34(3):316–320. doi:10.1086/669513
25. Gaur AH, Flynn PM, Giannini MA, Shenep JL, Hayden RT (2003) Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 37(4):469–475
26. Gaur AH, Miller MR, Gao C, Rosenberg C, Morrell GC, Coffin SE, Huskins WC (2013) Evaluating application of the national healthcare safety network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units. Infect Control Hosp Epidemiol 34(7):663–670. doi:10.1086/671005
27. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6(1):2–8
28. Handrup MM, Fuursted K, Funch P, Moller JK, Schroder H (2012) Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. APMIS 120(10):794–801. doi:10.1111/j.1600-0463.2012.02910.x
29. Handrup MM, Moller JK, Schroder H (2013) Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatr Blood Cancer 60(8):1292–1298. doi:10.1002/pbc.24482
30. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332. doi:10.1016/j.ajic.2008.03.002
31. Horvath B, Norville R, Lee D, Hyde A, Gregurich M, Hockenberry M (2009) Reducing central venous catheter-related bloodstream infections in children with cancer. Oncol Nurs Forum 36(2):232–238. doi:10.1188/09.ONF. 232-238
32. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R (1991) Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13(2):130–136
33. Kelly M, Conway M, Wirth K, Potter-Bynoe G, Billett AL, Sandora TJ (2011) Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol 32(11):1079–1085. doi:10.1086/662376
34. Krenn T, Fleischhack G, Moser O, Dilloo D, Bode U, Graber S, Furtwangler R, Graf N, Simon A (2011) Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals. Klin Padiatr 223(6):335–340. doi:10.1055/s-0031-1287838
35. Laws HJ, Ammann RA, Lehrnbecher T (2005) Diagnostic procedures and management of fever in pediatric cancer patients. Klin Padiatr 217(Suppl 1):9–16
36. Laws HJ, Kobbe G, Dilloo D, Dettenkofer M, Meisel R, Geisel R, Haas R, Gobel U, Schulze-Robbecke R (2005) Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. J Hosp Infect 62(1):80–88
37. Lee GM, Kleinman K, Soumerai SB, Tse A, Cole D, Fridkin SK, Horan T, Platt R, Gay C, Kassler W, Goldmann DA, Jernigan J, Jha AK (2012) Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 367(15):1428–1437. doi:10.1056/NEJMsa1202419
38. Lynn J, Baily MA, Bottrell M, Jennings B, Levine RJ, Davidoff F, Casarett D, Corrigan J, Fox E, Wynia MK, Agich GJ, O’Kane M, Speroff T, Schyve P, Batalden P, Tunis S, Berlinger N, Cronenwett L, Fitzmaurice JM, Dubler NN, James B (2007) The ethics of using quality improvement methods in health care. Ann Intern Med 146(9):666–673
39. Meckler G, Lindemulder S (2009) Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am 27(3):525–544. doi:10.1016/j.emc.2009.04.007
40. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45. doi:10.1086/599376
41. Miedema KG, Winter RH, Ammann RA, Droz S, Spanjaard L, de Bont ES, Kamps WA, van de Wetering MD, Tissing WJ (2013) Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia—species distribution and susceptibility patterns. Support Care Cancer 21(9):2417–2426. doi:10.1007/s00520-013-1797-4
42. Phillips B, Selwood K, Lane S, Skinner R, Gibson F, Chisholm JC (2007) Variation in policies for the management of febrile neutropenia in United Kingdom Children’s Cancer Study Group centres. Arch Dis Child 92(6):495–498
43. Rinke ML, Chen AR, Bundy DG, Colantuoni E, Fratino L, Drucis KM, Panton SY, Kokoszka M, Budd AP, Milstone AM, Miller MR (2012) Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics 130(4):e996–e1004. doi:10.1542/peds. 2012-0295
44. See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND (2013) Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 34(8):769–776. doi:10.1086/671281
45. Sexton DJ, Chen LF, Anderson DJ (2010) Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 31(12):1286–1289. doi:10.1086/657583
46. Shenep LE, Shenep MA, Cheatham W, Hoffman JM, Hale A, Williams BF, Perkins R, Hewitt CB, Hayden RT, Shenep JL (2011) Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization. J Hosp Infect 79(4):317–322. doi:10.1016/j.jhin.2011.07.010
47. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel P, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer M (2008) Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 university hospitals in Germany and Switzerland. BMC Infect Dis 8:70
48. Simon A, Ammann RA, Wiszniewsky G, Bode U, Fleischhack G, Besuden MM (2008) Taurolidine-citrate lock solution (TauroLock™) significantly reduces CVAD-associated Gram positive infections in paediatric cancer patients. BMC Infect Dis 8:102
49. Simon A, Beutel K, Marklein G, Fleischhack G (2005) Bacterial infections in pediatric cancer patients. Klin Padiatr 217(Suppl 1):17–36
50. Simon A, Bode U, Beutel K (2006) Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect 12(7):606–620
51. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH (2000) Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 21(9):592–596
52. Simon A, Fleischhack G, Wiszniewsky G, Hasan C, Bode U, Kramer MH (2006) Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resources. Infection 34(5):258–263
53. Simon A, Graf N, Furtwangler R (2013) Results of a multicentre survey evaluating clinical practice of Port and Broviac management in paediatric oncology. Klin Padiatr 225(3):145–151. doi:10.1055/s-0033-1333762
54. Simon A, Groger N, Wilkesmann A, Hasan C, Wiszniewsky G, Engelhart S, Kramer MH, Bode U, Ammann RA, Fleischhack G (2006) Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. Int J Antimicrob Agents 28(5):417–422
55. Taylor HA, Pronovost PJ, Faden RR, Kass NE, Sugarman J (2010) The ethical review of health care quality improvement initiatives: findings from the field. Issue Brief (Common Fund) 95:1–12
56. Urrea M, Rives S, Cruz O, Navarro A, Garcia JJ, Estella J (2004) Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study. Am J Infect Control 32(4):205–208
57. Wiersma P, Schillie S, Keyserling H, Watson JR, De A, Banerjee SN, Drenzek CL, Arnold KE, Shivers C, Kendrick L, Ryan LG, Jensen B, Noble-Wang J, Srinivasan A (2010) Catheter-related polymicrobial bloodstream infections among pediatric bone marrow transplant outpatients—Atlanta, Georgia, 2007. Infect Control Hosp Epidemiol 31(5):522–527. doi:10.1086/651668